158 related articles for article (PubMed ID: 30169614)
1. Lymphovascular invasion as a poor prognostic indicator in thoracic esophageal carcinoma: a systematic review and meta-analysis.
Wang A; Tan Y; Geng X; Chen X; Wang S
Dis Esophagus; 2019 Feb; 32(2):. PubMed ID: 30169614
[TBL] [Abstract][Full Text] [Related]
2. Lymphovascular invasion as a prognostic indicator in stage I non-small cell lung cancer: a systematic review and meta-analysis.
Mollberg NM; Bennette C; Howell E; Backhus L; Devine B; Ferguson MK
Ann Thorac Surg; 2014 Mar; 97(3):965-71. PubMed ID: 24424014
[TBL] [Abstract][Full Text] [Related]
3. Lymphovascular invasion as an independent prognostic indicator in radically resected thoracic esophageal squamous cell carcinoma.
Wang Z; Chen P; Wang F; Lin L; Liu S
Thorac Cancer; 2019 Feb; 10(2):150-155. PubMed ID: 30484962
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of lymphovascular invasion in bladder cancer after surgical resection: A meta-analysis.
Tian YF; Zhou H; Yu G; Wang J; Li H; Xia D; Xiao HB; Liu JH; Ye ZQ; Xu H; Zhuang QY
J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):646-655. PubMed ID: 26489616
[TBL] [Abstract][Full Text] [Related]
5. Relationship of lymphovascular invasion with lymph node metastasis and prognosis in superficial esophageal carcinoma: systematic review and meta-analysis.
Yang J; Lu Z; Li L; Li Y; Tan Y; Zhang D; Wang A
BMC Cancer; 2020 Mar; 20(1):176. PubMed ID: 32131772
[TBL] [Abstract][Full Text] [Related]
6. Proposal on incorporating lymphovascular invasion as a T-descriptor for stage I lung cancer.
Wang S; Zhang B; Qian J; Qiao R; Xu J; Zhang L; Zhao Y; Zhang Y; Wang R; Zhao R; Han B
Lung Cancer; 2018 Nov; 125():245-252. PubMed ID: 30429028
[TBL] [Abstract][Full Text] [Related]
7. Lymphovascular invasion is a high risk factor for stage I/II colorectal cancer: a systematic review and meta-analysis.
Yuan H; Dong Q; Zheng B; Hu X; Xu JB; Tu S
Oncotarget; 2017 Jul; 8(28):46565-46579. PubMed ID: 28430621
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of lymphovascular invasion in lymph node-negative superficial esophageal squamous cell carcinoma.
Oguma J; Ozawa S; Kazuno A; Yamamoto M; Ninomiya Y; Yatabe K; Makuuchi H; Ogura G
Dis Esophagus; 2019 Dec; 32(11):. PubMed ID: 30883635
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value of separate lymphatic invasion and vascular invasion in oesophageal squamous cell carcinoma: a meta-analysis and systematic review.
Wang A; Tan Y; Wang S; Chen X
BMC Cancer; 2022 Dec; 22(1):1329. PubMed ID: 36536299
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of lymphovascular invasion in patients with esophageal squamous cell carcinoma treated with neoadjuvant chemoradiotherapy.
Chen WH; Huang YL; Chao YK; Yeh CJ; Chang HK; Tseng CK; Liu YH
Ann Surg Oncol; 2015 Jan; 22(1):338-43. PubMed ID: 25023545
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of lymphovascular invasion in upper urinary tract urothelial carcinoma is influenced by tumor location.
Lee HY; Li CC; Huang CN; Ke HL; Li WM; Liang PI; Yang SF; Tu HP; Wu WJ; Yeh HC
Ann Surg Oncol; 2015 Apr; 22(4):1392-400. PubMed ID: 25239005
[TBL] [Abstract][Full Text] [Related]
12. Lymphovascular invasion and presence of embryonal carcinoma as risk factors for occult metastatic disease in clinical stage I nonseminomatous germ cell tumour: a systematic review and meta-analysis.
Blok JM; Pluim I; Daugaard G; Wagner T; Jóźwiak K; Wilthagen EA; Looijenga LHJ; Meijer RP; Bosch JLHR; Horenblas S
BJU Int; 2020 Mar; 125(3):355-368. PubMed ID: 31797520
[TBL] [Abstract][Full Text] [Related]
13. Presence of lymphovascular invasion in urothelial bladder cancer specimens after transurethral resections correlates with risk of upstaging and survival: a systematic review and meta-analysis.
Kim HS; Kim M; Jeong CW; Kwak C; Kim HH; Ku JH
Urol Oncol; 2014 Nov; 32(8):1191-9. PubMed ID: 24954108
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of lymphovascular invasion in upper urinary tract urothelial cancer.
Akao J; Matsuyama H; Yamamoto Y; Hara T; Kawai Y; Sakano S; Ohmi C; Gondo T; Naito K
BJU Int; 2008 Aug; 102(5):572-5. PubMed ID: 18485032
[TBL] [Abstract][Full Text] [Related]
15. Routinely reported 'equivocal' lymphovascular invasion in prostatectomy specimens is associated with adverse outcomes.
Galiabovitch E; Hovens CM; Peters JS; Costello AJ; Battye S; Norden S; Ryan A; Corcoran NM
BJU Int; 2017 Apr; 119(4):567-572. PubMed ID: 27431748
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of lymphovascular invasion in transitional cell carcinoma of upper urinary tract.
Hong B; Park S; Hong JH; Kim CS; Ro JY; Ahn H
Urology; 2005 Apr; 65(4):692-6. PubMed ID: 15833510
[TBL] [Abstract][Full Text] [Related]
17. Duplicated muscularis mucosae invasion has similar risk of lymph node metastasis and recurrence-free survival as intramucosal esophageal adenocarcinoma.
Estrella JS; Hofstetter WL; Correa AM; Swisher SG; Ajani JA; Lee JH; Bhutani MS; Abraham SC; Rashid A; Maru DM
Am J Surg Pathol; 2011 Jul; 35(7):1045-53. PubMed ID: 21602659
[TBL] [Abstract][Full Text] [Related]
18. Identification and Validation of Lymphovascular Invasion as a Prognostic and Staging Factor in Node-Negative Esophageal Squamous Cell Carcinoma.
Huang Q; Luo K; Chen C; Wang G; Jin J; Kong M; Li B; Liu Q; Li J; Rong T; Chen H; Zhang L; Chen Y; Zhu C; Zheng B; Wen J; Zheng Y; Tan Z; Xie X; Yang H; Fu J
J Thorac Oncol; 2016 Apr; 11(4):583-92. PubMed ID: 26792626
[TBL] [Abstract][Full Text] [Related]
19. Lymphovascular invasion in non-small-cell lung cancer: implications for staging and adjuvant therapy.
Higgins KA; Chino JP; Ready N; D'Amico TA; Berry MF; Sporn T; Boyd J; Kelsey CR
J Thorac Oncol; 2012 Jul; 7(7):1141-7. PubMed ID: 22617241
[TBL] [Abstract][Full Text] [Related]
20. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy.
Lotan Y; Gupta A; Shariat SF; Palapattu GS; Vazina A; Karakiewicz PI; Bastian PJ; Rogers CG; Amiel G; Perotte P; Schoenberg MP; Lerner SP; Sagalowsky AI
J Clin Oncol; 2005 Sep; 23(27):6533-9. PubMed ID: 16116151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
